Participant flow

sdAb-based TRNT of Multiple Myeloma: a Feasibility Study · Source last updated 2021-12-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   Only 1 arm/group in this trial - Patients with a clinically suspected or pathologically confirmed multiple myeloma.

   id

   FG000

   title

   Clinically Suspected or Pathologically Confirmed Multiple Myeloma.

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      No multiple myeloma confirmed

   2. reasons

      1. group Id

         FG000

         num Subjects

         1

      type

      Assessment of membrane-expressed ideotypic paraprotein not possible due to low CD38 signals

   3. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      No expression of ideotypic paraprotein on membrane

   4. reasons

      1. group Id

         FG000

         num Subjects

         2

      type

      Not selected for sdAb generation, due to limitation of total number to 3

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         10

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         3

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         7

      type

      NOT COMPLETED

   title

   Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice